Clay Hamlin

Clay W Hamlin, III is an American Businessman from Buffalo, New York. Mr. Hamlin is a Director, former CEO, and second largest individual shareholder of Corporate Office Properties Trust (NYSE: OFC), which he co-founded in 1997.In his eight years as CEO, the Company grew to an enterprise value in excess of $4 billion, and received the highest total shareholder return of all publicly traded REITs. Mr. Hamlin is the Founder, President and Chief Executive Officer of LBCW Investments, a privately held investment company investing in private equity, structured debt, and special opportunities, as well as public debt and equity securities. He is the Founder of and a Managing Partner at Alliance Partners, HSP, LLC, a billion-dollar real estate operating company. Mr. Hamlin is the Chief Executive Officer of CITRS, a non-profit character education company catering to k-12 schools, and the President of the Hamlin Family Foundation.

Education

Clay received his undergraduate degree, earning the Class of 1915 Award for the Ideal Scholar/Athlete from The University of Pennsylvania. He is a former All Ivy tennis player and a member of the University of Pennsylvania Tennis Hall of Fame. Mr. Hamlin received an MBA in accounting and finance from The Wharton School, University of Pennsylvania and a Juris Doctor degree from Temple University, and previously practiced as a Certified Public Accountant and as a corporate, tax and real estate lawyer. Clay also served as a Lieutenant J.G. on the U.S. Navy aircraft carrier, USS Wasp, in the late 1960s.

The Project to End Prostate Cancer/National Prostate Cancer Coalition

In 2001, Clay Hamlin joined the board of the Prostate Cancer Foundation which is the leading philanthropic organization funding and accelerating prostate cancer research globally. Mr. Hamlin teamed up with Michael Milken, founder of the Prostate Cancer Foundation (PCF) to start the Philly Against Prostate Cancer annual event.The Philly Against Prostate Cancer 2014 event raised over $1 million for local physicians and scientists in their research and goal of finding a cure.